Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
Lusha W LiangYoshihiko RaitaKohei HasegawaMichael A FiferMathew S MaurerMuredach P ReillyYuichi J ShimadaPublished in: Heart (British Cardiac Society) (2022)
Our prospective plasma proteomics study not only exhibited the presence of HCM molecular subtypes but also identified pathobiological mechanisms associated with a distinct high-risk subtype of HCM.